No Benefit of Postoperative Dalteparin Bridging Treatment for Preventing Thromboembolism
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Postoperative Low Molecular Weight Heparin Bridging Treatment for Patients at High Risk of Arterial Thromboembolism (PERIOP2): Double Blind Randomised Controlled Trial
BMJ 2021 Jun 09;[EPub Ahead of Print], MJ Kovacs, PS Wells, DR Anderson, A Lazo-Langner, C Kearon, SM Bates, M Blostein, SR Kahn, S Schulman, E Sabri, S Solymoss, T Ramsay, E Yeo, MA RodgerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.